features: Amyotrophic Lateral Sclerosis

AMX0035 receives FDA approval for ALS

On September 29, 2022, the Food and Drug Administration (FDA) approved AMX0035 for the treatment of amyotrophic lateral sclerosis (ALS),…

Read More

Top clinical trial updates from AAN 2021: MG, PD & ALS

Discover updates from major clinical trials in myasthenia gravis, Parkinson’s disease & ALS presented at AAN 2021!

Read More
The content of VJNeurology is intended for healthcare professionals